GIP-Overexpressing Mice Demonstrate Reduced Diet-Induced Obesity and Steatosis, and Improved Glucose Homeostasis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone that potentiates glucose-stimulated insulin secretion during a meal. Since GIP has also been shown to exert β-cell prosurvival and adipocyte lipogenic effects in rodents, both GIP receptor agonists and antagonists have been considered as potential therapeutics in type 2 diabetes (T2DM). In the present study, we tested the hypothesis that chronically elevating GIP levels in a transgenic (Tg) mouse model would increase adipose tissue expansion and exert beneficial effects on glucose homeostasis. In contrast, although GIP Tg mice demonstrated enhanced β-cell function, resulting in improved glucose tolerance and insulin sensitivity, they exhibited reduced diet-induced obesity. Adipose tissue macrophage infiltration and hepatic steatosis were both greatly reduced, and a number of genes involved in lipid metabolism/inflammatory signaling pathways were found to be down-regulated. Reduced adiposity in GIP Tg mice was associated with decreased energy intake, involving overexpression of hypothalamic GIP. Together, these studies suggest that, in the context of over-nutrition, transgenic GIP overexpression has the potential to improve hepatic and adipocyte function as well as glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The precise effects of GIP on lipid metabolism are currently unclear; some studies suggest it may increase lipid uptake in adipose tissue and decrease lipolysis [53,54], while others suggest GIP may have lipolytic activity, as adipose tissue from transgenic mice overexpressing GIP has been found to be resistant to high-fat feeding [55,56].”
From New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists (2024) · cites this paper as [56]
In the citing paper
“Notwithstanding, significant general GIP overexpression prevents obesity and lowers inflammatory markers in mice [123].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 1×
“gastric emptying and food intake [5–9].”
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962 · cited 1×
“needed [3–4].”
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662 · cited 1×
“lowering carbohydrate digestion [1–2].”
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“In a recent study, it was demonstrated that overexpression of adiponectin in mice on an ob/ob genetic background resulted in greater obesity, compared to non-transgenic animals, but with marked improvements in both glucose tolerance and insulin resistance, as well as reduced circulating TG and hepatic steatosis [31].”
BackgroundMitochondrial biogenesis in mammals: the role of endogenous nitric oxide
Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S., et al. (2003) · Science · doi:10.1126/science.1079368 · Cited by 1,243 · cited 1×
“eNos has been linked to the induction of PGC-1a expression [38–39] and both PGC-1a [40] and Ucp2 [41] are involved in mitochondrial biogenesis, reduction of which may contribute to lowering ROS production.”
BackgroundInhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963 · cited 3×
“No significant differences in energy expenditure, determined by indirect calorimetry, were apparent between Het GIP Tg mice and WT littermates on either LF or HF diets (Figure 5A and Figure S1), whereas higher energy expenditure was reported for GIPRKO mice [22].”
BackgroundMethodResultThe role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614 · cited 1×
“gastric emptying and food intake [5–9].”
Sethi, J. K., & Vidal-Puig, A. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700005-jlr200 · Cited by 563
Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0015 · Cited by 540
Miyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454 · cited 1×
“In view of the glucose intolerance but resistance to diet-induced obesity observed in GIPR knockout mice [22,33–34], the current study was initiated to test the hypothesis that chronically elevating GIP levels in vivo would increase adipose tissue expansion and exert beneficial effects on glucose homeostasis.”
BackgroundTNF- downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents
Valerio, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28570 · Cited by 327 · cited 1×
“eNos has been linked to the induction of PGC-1a expression [38–39] and both PGC-1a [40] and Ucp2 [41] are involved in mitochondrial biogenesis, reduction of which may contribute to lowering ROS production.”
BackgroundExtrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., & Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci25483 · Cited by 290 · cited 1×
“As would be anticipated, these changes in locomotor activity were opposite to those reported for GIPRKO mice [22,34].”
ResultButler, A. A., & Kozak, L. P. (2010) · Diabetes · doi:10.2337/db09-1471 · Cited by 263 · cited 1×
“This apparent discrepancy may be partly due to the fact that energy expenditure was normalized to lean body mass (LBM), as recently recommended [45], since a unit of fat mass has a lower level of oxygen consumption than a unit of lean mass [45].”
BackgroundPharmacological Agents That Directly Modulate Insulin Secretion
Doyle, M. E., & Egan, J. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.7 · Cited by 256 · cited 1×
“lowering carbohydrate digestion [1–2].”
McClean, P. L., Irwin, N., Cassidy, R. S., Holst, J. J., Gault, V. A., & Flatt, P. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00460.2007 · Cited by 239 · cited 1×
“treatment [25], reducing circulating GIP levels with K-cell”
MethodPeroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
Crunkhorn, S., Dearie, F., Mantzoros, C., Gami, H., da Silva, W. S., Espinoza, D., Faucette, R., Barry, K., Bianco, A. C., & Patti, M. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611214200 · Cited by 236 · cited 1×
“eNos has been linked to the induction of PGC-1a expression [38–39] and both PGC-1a [40] and Ucp2 [41] are involved in mitochondrial biogenesis, reduction of which may contribute to lowering ROS production.”
BackgroundActivation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609088200 · Cited by 216 · cited 2×
“tion [14–21].”
BackgroundSelf-citationPalmiter, R. D., Sandgren, E. P., Koeller, D. M., & Brinster, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5266 · Cited by 209 · cited 2×
“GIP-overexpressing transgenic mice were generated using a gene construct containing the GIP coding sequence flanked by regulatory regions from the endogenous metallothionein locus (MTI and MTII) [55], resulting in a construct that retains proper regulation with limited artifactual effects derived from the site of inte…”
BackgroundPGC1α Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis
Bhalla, K., Hwang, B. J., Dewi, R. E., Ou, L., Twaddel, W., Fang, H.-B., Vafai, S. B., Vazquez, F., Puigserver, P., Boros, L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1011 · Cited by 190
Jayasooriya, A. P., Mathai, M. L., Walker, L. L., Begg, D. P., Denton, D. A., Cameron-Smith, D., Egan, G. F., McKinley, M. J., Rodger, P. D., Sinclair, A. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802690105 · Cited by 185 · cited 1×
“Also of interest was the reduced expression of the angiotensin converting enzyme gene (Ace) since angiotensin II is involved in increasing fat deposition [36], activation of nitric oxide synthase 3 (eNos) and modulating the macrophage phenotype [37].”
BackgroundAlthage, M. C., Ford, E. L., Wang, S., Tso, P., Polonsky, K. S., & Wice, B. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710466200 · Cited by 180 · cited 1×
“ablation [26] or vaccination against GIP [27] may be beneficial”
BackgroundChapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S., & Kim, S. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 171 · cited 1×
“is consistent with its anabolic characteristics [9].”
Self-citationA Systematic Review of Drug Therapy to Delay or Prevent Type 2 Diabetes
Padwal, R., Majumdar, S. R., Johnson, J. A., Varney, J., & McAlister, F. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.736 · Cited by 164 · cited 1×
“needed [3–4].”
Park, J., Choe, S. S., Choi, A. H., Kim, K. H., Yoon, M. J., Suganami, T., Ogawa, Y., & Kim, J. B. (2006) · Diabetes · doi:10.2337/db05-1570 · Cited by 156
Kurrasch, D. M., Cheung, C. C., Lee, F. Y., Tran, P. V., Hata, K., & Ingraham, H. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2858-07.2007 · Cited by 153 · cited 1×
“The VMN is a major site for PACAP biosynthesis [50], with mRNA expression regulated by energy status [51].”
BackgroundYe, J.-M., Dzamko, N. L., Cleasby, M. E., Hegarty, B. D., Furler, S. M., Cooney, G. J., & Kraegen, E. W. (2004) · Diabetologia · doi:10.1007/s00125-004-1436-1 · Cited by 151 · cited 1×
“Storage of fat preferentially in adipose tissue and partitioning it away from other insulin-sensitive tissues is therefore probably a major determinant of insulin sensitivity and normal glucose tolerance, an effect of thiazolidinediones that has been termed: ‘lipid steal’ [32].”
BackgroundTedesco, L., Valerio, A., Dossena, M., Cardile, A., Ragni, M., Pagano, C., Pagotto, U., Carruba, M. O., Vettor, R., & Nisoli, E. (2010) · Diabetes · doi:10.2337/db09-1881 · Cited by 147 · cited 1×
“biogenesis is reduced by p38 MAPK activation [42], a target of GIP signaling.”
BackgroundGlucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass
Xie, D., Zhong, Q., Ding, K.-H., Cheng, H., Williams, S., Correa, D., Bollag, W. B., Bollag, R. J., Insogna, K., Troiano, N., et al. (2007) · Bone · doi:10.1016/j.bone.2007.01.007 · Cited by 144
Self-citationSong, D. H., Getty–Kaushik, L., Tseng, E., Simon, J., Corkey, B. E., & Wolfe, M. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.005 · Cited by 137 · cited 1×
“tion [14–21].”
Vaccination against GIP for the Treatment of Obesity
Fulurija, A., Lutz, T. A., Sladko, K., Osto, M., Wielinga, P. Y., Bachmann, M. F., & Saudan, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003163 · Cited by 136 · cited 1×
“ablation [26] or vaccination against GIP [27] may be beneficial”
BackgroundGlucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification
Getty‐Kaushik, L., Song, D. H., Boylan, M. O., Corkey, B. E., & Wolfe, M. M. (2006) · Obesity · doi:10.1038/oby.2006.129 · Cited by 134 · cited 1×
“tion [14–21].”
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006841 · Cited by 133 · cited 2×
“tion [14–21].”
BackgroundSelf-citationIrwin, N., & Flatt, P. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1422-8 · Cited by 133 · cited 1×
“[23–24].”
Hinke, S. A., Gelling, R. W., Pederson, R. A., Manhart, S., Nian, C., Demuth, H.-U., & McIntosh, C. H. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.652 · Cited by 131
Self-citationKim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704896200 · Cited by 118
Self-citationNyberg, J., Jacobsson, C., Anderson, M. F., & Eriksson, P. S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21349 · Cited by 117 · cited 1×
“GIP was reported to be highly expressed in the hippocampus and thalamus of adult rat brain, while its expression in rat hypothalamus was relatively low [48], and it was previously shown that GIP expression in the brain was increased in the GIP Tg mouse strain [29,49].”
BackgroundMillward, C. A., DeSantis, D., Hsieh, C., Heaney, J. D., Pisano, S. G., Olswang, Y., Reshef, L., Beidelschies, M. A., Puchowicz, M., & Croniger, C. M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m005363 · Cited by 111 · cited 1×
“Downregulation of Ppargc1a and Acly would be expected to reduce fatty acid synthesis, whereas reduced Pck1 expression would lower rates of glyceroneogenesis and reesterification [43,44].”
BackgroundPACAP Neurons in the Hypothalamic Ventromedial Nucleus Are Targets of Central Leptin Signaling
Hawke, Z., Ivanov, T. R., Bechtold, D. A., Dhillon, H., Lowell, B. B., & Luckman, S. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1526-09.2009 · Cited by 105 · cited 1×
“The VMN is a major site for PACAP biosynthesis [50], with mRNA expression regulated by energy status [51].”
BackgroundFaivre, E., Gault, V. A., Thorens, B., & Hölscher, C. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00866.2010 · Cited by 104 · cited 1×
“A number of effects of GIP on central nervous functions have been demonstrated, including improved cognition, hippocampal synaptic plasticity and glucose homeostasis [46], whereas GIPRKO mice demonstrated impairments in learning, synaptic plasticity and neurogenesis [47].”
BackgroundWidenmaier, S. B., Kim, S.-J., Yang, G. K., De Los Reyes, T., Nian, C., Asadi, A., Seino, Y., Kieffer, T. J., Kwok, Y. N., & McIntosh, C. H. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009590 · Cited by 102 · cited 3×
“Subcutaneous administration of D-Ala2-GIP1–30 to Zucker diabetic fatty rats resulted in significantly improved glucose tolerance and insulin sensitivity, with a mild effect on food intake [13].”
BackgroundResultSelf-citationGniuli, D., Calcagno, A., Libera, L. D., Calvani, R., Leccesi, L., Caristo, M. E., Vettor, R., Castagneto, M., Ghirlanda, G., & Mingrone, G. (2010) · Diabetologia · doi:10.1007/s00125-010-1830-9 · Cited by 99
Porter, D. W., Irwin, N., Flatt, P. R., Hölscher, C., & Gault, V. A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.059 · Cited by 93 · cited 2×
“However, peripherally administrated GIP analogues have recently been reported to cross the blood-brainbarrier and exert central effects in mice [46,54].”
BackgroundFaivre, É., Hamilton, A., & Hölscher, C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.007 · Cited by 73 · cited 1×
“However, peripherally administrated GIP analogues have recently been reported to cross the blood-brainbarrier and exert central effects in mice [46,54].”
BackgroundMcIntosh, C. H. S., Bremsak, I., Lynn, F. C., Gill, R., Hinke, S. A., Gelling, R., Nian, C., McKnight, G., Jaspers, S., & Pederson, R. A. (1999) · Endocrinology · doi:10.1210/endo.140.1.6464 · Cited by 73
Self-citationEffects of glucose-dependent insulinotropic peptide on behavior
Ding, K., Zhong, Q., Xie, D., Chen, H.-X., Della‐Fera, M. A., Bollag, R. J., Bollag, W. B., Gujral, R., Kang, B., Sridhar, S., et al. (2006) · Peptides · doi:10.1016/j.peptides.2006.05.011 · Cited by 64
Gault, V. A., Porter, D., Irwin, N., & Flatt, P. R. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0419 · Cited by 64 · cited 2×
“However, in carefully controlled studies, subcutaneous administration of GIP1-42 or GIP1-30 in HF fed mice was not found to have any major effects on food intake or body weight, despite significantly improved metabolic profiles [11].”
BackgroundResultMohammad, S., Ramos, L. S., Buck, J., Levin, L. R., Rubino, F., & McGraw, T. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289009 · Cited by 59
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012203 · Cited by 58
Self-citationIrwin, N., Gault, V., & Flatt, P. R. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.513381 · Cited by 53 · cited 1×
“diabetic rats, as well as in high fat (HF) fed mice [10–12].”
BackgroundKohlstedt, K., Trouvain, C., Namgaladze, D., & Fleming, I. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0137-9 · Cited by 53 · cited 1×
“Also of interest was the reduced expression of the angiotensin converting enzyme gene (Ace) since angiotensin II is involved in increasing fat deposition [36], activation of nitric oxide synthase 3 (eNos) and modulating the macrophage phenotype [37].”
BackgroundPleiotropic Actions of the Incretin Hormones
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 46 · cited 1×
“gastric emptying and food intake [5–9].”
Self-citationUncoupling Protein-2 and the Potential Link Between Metabolism and Longevity
Andrews, Z. B. (2010) · Current Aging Science · doi:10.2174/1874609811003020102 · Cited by 44 · cited 3×
“eNos has been linked to the induction of PGC-1a expression [38–39] and both PGC-1a [40] and Ucp2 [41] are involved in mitochondrial biogenesis, reduction of which may contribute to lowering ROS production.”
BackgroundKerr, B. D., Irwin, N., O'Harte, F. P. M., Bailey, C. J., Flatt, P. R., & Gault, V. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.037 · Cited by 44 · cited 1×
“Additionally, administration of a range of long acting GIP analogues, including N-acGIP, GIP (LysMYR), N-AcGIP(LysMYR) and N-AcGIP(LysPAL), had no effect on body weight and food intake when compared to saline-treated controls [52–53].”
BackgroundHinke, S., Pauly, R., Ehses, J., Kerridge, P., Demuth, H., McIntosh, C., & Pederson, R. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650281 · Cited by 24 · cited 1×
“Since the GIP receptor undergoes down-regulation with prolonged exposure to elevated GIP [28], we next determined whether blunted GIP responses contributed to the phenotype demonstrated by Het GIP Tg mice.”
BackgroundSelf-citationIrwin, N., Green, B. D., Gault, V. A., Cassidy, R. S., O'Harte, F. P. M., Harriott, P., & Flatt, P. R. (2005) · Peptides · doi:10.1016/j.peptides.2005.08.003 · Cited by 21
Cited by
Coskun, T., Sloop, K. W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K. B., Cui, X., Briere, D. A., Cabrera, O., Roell, W. C., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.009 · Cited by 882
“Chronically elevating GIP levels in a transgenic mouse model has been shown to reduce diet-induced obesity (DIO) and improve insulin sensitivity, glucose tolerance, and beta-cell function [30].”
BackgroundUnimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
“Likewise, mice treated with GIP analogs (36) or with transgenic GIP overexpression (14) are also protected from diet-induced obesity.”
BackgroundTargeting fibrosis: mechanisms and clinical trials
Zhao, M., Wang, L., Wang, M., Zhou, S., Lu, Y., Cui, H., Racanelli, A. C., Zhang, L., Ye, T., Ding, B., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01070-3 · Cited by 547
How May GIP Enhance the Therapeutic Efficacy of GLP-1?
Samms, R. J., Coghlan, M. P., & Sloop, K. W. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.006 · Cited by 419
Nauck, M. A., Quast, D. R., Wefers, J., & Pfeiffer, A. F. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14496 · Cited by 388
Metadata
- Authors
- Kim, S.-J., Nian, C., Karunakaran, S., Clee, S. M., Isales, C. M., & McIntosh, C. H. S.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McIntosh, Christopher H. S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-07-03
- Volume
- 7
- Issue
- 7
- Pages
- e40156
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3388996
- OpenAlex
- W2072686461
- Cited by
- 182
- References
- 55
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 28 · 2023: 18 · 2022: 18 · 2021: 14 · 2020: 17 · 2019: 21 · 2018: 12 · 2017: 5 · 2016: 13 · 2015: 5 · 2014: 7 · 2013: 7 · 2012: 1
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Canadian Diabetes Association
- Michael Smith Health Research BC
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- glucose-dependent insulinotropic polypeptide, diet-induced obesity, hepatic steatosis, glucose homeostasis, insulin sensitivity, beta-cell function, adipose tissue macrophage infiltration, energy intake, lipid metabolism, inflammation, type 2 diabetes, transgenic mice
- MeSH terms
- Adipose Tissue, Animals, Energy Metabolism, Fatty Liver, Gastric Inhibitory Polypeptide, Glucose, Glucose Tolerance Test, Homeostasis, Insulin Resistance, Male, Mice, Transgenic, Obesity, Glucose Intolerance, Mice, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.